PMID- 32419595 OWN - NLM STAT- MEDLINE DCOM- 20201102 LR - 20221207 IS - 1545-1550 (Electronic) IS - 1526-6028 (Linking) VI - 27 IP - 4 DP - 2020 Aug TI - A Global Vascular Guidelines-Based Bypass-Preferred Population and Their Surgical Risk Among CLTI Patients Treated With Endovascular Therapy in a Real-World Practice. PG - 608-613 LID - 10.1177/1526602820924338 [doi] AB - PURPOSE: To determine in a chronic limb-threatening ischemia (CLTI) population who underwent endovascular therapy (EVT) how many patients would have been categorized as preferred for bypass surgery according to the Global Vascular Guidelines (GVG) and ascertain their surgical risk. MATERIALS AND METHODS: The current study analyzed 1043 CLTI patients who presented WIfI (wound, ischemia, and foot infection) stage >/=2 and underwent EVT between April 2010 and December 2017. Of these, 176 were excluded for lack of angiographic or other data, leaving 867 CLTI patients (mean age 74+/-10 years; 523 men) for stratification according to the GVG into bypass-preferred, indeterminate, or EVT-preferred groups. The GVG recommend bypass as the first-line treatment when the wound is severe (WIfI stage >/=3) and lesions are complex (GLASS stage III). Surgical risk was estimated using the modified PREVENT III risk score. To further stratify the bypass-preferred population according to mortality risk, a survival decision tree was constructed using recursive partitioning. RESULTS: The bypass-preferred group accounted for 55% [95% confidence interval (CI) 51% to 58%] of the overall population. The decision tree analysis extracted a low-mortality risk subgroup with a survival rate of 99% (95% CI 98% to 100%) at 1 month and 80% (95% CI 73% to 87%) at 2 years. According to the PREVENT III score, 34% (95% CI 27% to 42%) of the low mortality risk subgroup were classified as high surgical risk. CONCLUSION: A high proportion of patients undergoing EVT were considered bypass preferred based on the GVG, and the survival of these patients was not significantly different whether they were high or low surgical risk. FAU - Okamoto, Shin AU - Okamoto S AUID- ORCID: 0000-0002-9178-5514 AD - Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. FAU - Iida, Osamu AU - Iida O AUID- ORCID: 0000-0001-6829-7304 AD - Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. FAU - Takahara, Mitsuyoshi AU - Takahara M AD - Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Suita, Japan. FAU - Hata, Yosuke AU - Hata Y AUID- ORCID: 0000-0001-5482-3502 AD - Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. FAU - Asai, Mitsutoshi AU - Asai M AD - Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. FAU - Masuda, Masaharu AU - Masuda M AD - Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. FAU - Ishihara, Takayuki AU - Ishihara T AD - Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. FAU - Nanto, Kiyonori AU - Nanto K AD - Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. FAU - Kanda, Takashi AU - Kanda T AD - Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. FAU - Tsujimura, Takuya AU - Tsujimura T AUID- ORCID: 0000-0002-3128-1357 AD - Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. FAU - Okuno, Syota AU - Okuno S AD - Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. FAU - Matsuda, Yasuhiro AU - Matsuda Y AD - Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. FAU - Mano, Toshiaki AU - Mano T AD - Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. LA - eng PT - Journal Article DEP - 20200518 PL - United States TA - J Endovasc Ther JT - Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists JID - 100896915 SB - IM CIN - J Endovasc Ther. 2020 Aug;27(4):614-615. PMID: 32495685 MH - Aged MH - Aged, 80 and over MH - Amputation, Surgical/standards MH - Chronic Disease MH - *Clinical Decision-Making MH - Endovascular Procedures/adverse effects/mortality/*standards MH - Female MH - Guideline Adherence/standards MH - Humans MH - Ischemia/diagnosis/mortality/*therapy MH - Limb Salvage/standards MH - Male MH - Middle Aged MH - *Patient Selection MH - Peripheral Arterial Disease/diagnosis/mortality/*therapy MH - Practice Guidelines as Topic/*standards MH - Retrospective Studies MH - Risk Assessment MH - Risk Factors MH - Time Factors MH - Treatment Outcome MH - Vascular Grafting/adverse effects/mortality/*standards OTO - NOTNLM OT - Bypass surgery OT - Global Vascular Guidelines OT - chronic limb-threatening ischemia OT - endovascular therapy OT - mortality risk OT - peripheral artery disease OT - surgical risk OT - survival EDAT- 2020/05/19 06:00 MHDA- 2020/11/03 06:00 CRDT- 2020/05/19 06:00 PHST- 2020/05/19 06:00 [pubmed] PHST- 2020/11/03 06:00 [medline] PHST- 2020/05/19 06:00 [entrez] AID - 10.1177/1526602820924338 [doi] PST - ppublish SO - J Endovasc Ther. 2020 Aug;27(4):608-613. doi: 10.1177/1526602820924338. Epub 2020 May 18.